Evidence map›Paper›PMID 42614622›Full record

ReviewACS pharmacology & translational science2026

Machine-Learning-Driven Optimization of Functional Excipients and Their Biointeractions in Drug Formulations.

Xiaoyue Liu, Liulu Xie, Wei Chen

Abstract readReview
In one paragraph

Review in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoyue LiuDepartment of Biomedical Engineering, National University of Singapore, Singapore 117583, Singapore.
Liulu XieDepartment of Pharmacology, School of Basic Medicine, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Wei ChenDepartment of Pharmacology, School of Basic Medicine, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.ORCID https://orcid.org/0000-0003-3611-2760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional excipients are increasingly recognized as active components in drug formulations because they can influence drug stability, solubility, release behavior, delivery efficiency, biological barrier penetration, transporter activity, and metabolic clearance. Machine learning is becoming useful in formulation research because it can connect scattered formulation data to excipient selection, property prediction, and experimental decision-making. In particular, machine learning models can help extract useful patterns from fragmented formulation data, prioritize candidate excipients, and guide formulation decisions before extensive experimental screening. This review summarizes recent advances in machine-learning-driven optimization of functional excipients and their biointeractions in drug formulations. We first discuss the methodological foundations of this field, including data acquisition, feature engineering, model architecture selection, optimization, and evaluation strategies. Representative application scenarios are then reviewed, including the identification of functional excipients related to drug efflux inhibition, formulation stability enhancement, biological barrier penetration, and metabolic clearance reduction. This review also discusses practical barriers that still limit this field related to data quality, representation design, experimental feedback, computational cost, and deployability. These issues need to be addressed before artificial intelligence (AI)-assisted formulation systems can become reliable tools for routine pharmaceutical development.

Indexed as

AI-assisted formulation optimizationbiointeractionfunctional excipientinterdisciplinary researchmachine learning

Identifiers

PMID42614622
PMCPMC13482887

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.